Sun Pharma Q2 Profit Plummets 36% YoY to Rs 1,989 Crore Due to Exceptional Charges.
Sun Pharmaceutical Industries reported a significant 36% year-on-year decline in consolidated net profit for the September quarter, amounting to Rs
Read MoreSun Pharmaceutical Industries reported a significant 36% year-on-year decline in consolidated net profit for the September quarter, amounting to Rs
Read MoreThe latest data indicates a significant shift in foreign institutional investors’ (FIIs) engagement with the Indian equity market for the
Read MoreAn acute global shortage of diesel has enabled Indian refiners to increase their exports significantly, reaching 2.90 million tonnes in
Read MoreThe primary market in India is gearing up for an exciting Friday, October 30, with four SME IPOs set to
Read MoreSilver prices experienced a significant downturn, trading 2.59% lower at $50.80 per ounce in New York. On the Multi Commodity
Read MoreThe European Central Bank (ECB) is poised to implement a rate hike in December, responding to mounting inflation concerns primarily
Read MoreThe eagerly awaited BLS Polymers IPO is set to finalize its allotment today ahead of its listing on the Bombay
Read MoreNasscom has formally requested a two-month deferment of the revised Goods and Services Tax (GST) treatment for delivery services offered
Read MoreIndian rice export prices have maintained stability this week, hovering near their highest levels in over a year. Currently, India’s
Read MoreRecent developments in the technology sector have heightened concerns among investors regarding the sustainability of the AI boom. Despite previous
Read More